|
|
Med BioGene Inc. (MBI: TSX Venture) is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic and screening tests for cancer and cardiovascular disease.
Their lead product is LymphExpress Dx™, a genomic-based diagnostic test for lymphoma. MBI is also developing tests for leukemia and cardiovascular disease through LeukExpress Dx™ and CardioExpress Dx™.
MBI’s products are expected to provide more accurate, quicker and less invasive diagnosis, allowing healthcare providers to deliver more appropriate and timely care to patients.
Visit Med BioGene's Website
- CORPORATE PROFILE
- PRESENTATIONS
| NEWS |
|
| June 16, 2008 |
Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies |
| May 29, 2008 |
Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann to Board of Directors |
| April 30, 2008 |
Med BioGene Reports Financial Results for 2007 |
| April 23, 2008 |
Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test |
| April 3, 2008 |
Med BioGene Confirms High Accuracy Rate for LymphExpress Dx(TM) |
| February 19, 2008 |
Med BioGene Appoints Diagnostics Industry Veteran Dennis L. Grimaud to Board of Directors |
| January 23, 2008 |
Letter From CEO Erinn Broshko To Shareholders |
| November 28, 2007 |
Med BioGene Inc. Reports Financial Results for the Third Quarter 2007 |
| October 25, 2007 |
Med BioGene Engages U.S. Consulting Firm to Drive Partnering Efforts |
| September 24, 2007 |
Med BioGene Welcomes Renowned Expert to Lymphoma Collaboration |
| September 12, 2007 |
Med BioGene Appoints Dr. Melanie M. Mahtani as Executive Advisor, Commercial Development |
| July 30, 2007 |
Med BioGene Inc.: Dr. Nathan Yoganathan, President and Chief Scientific Officer, Transitions to Senior Advisory Role; Dr. Bradley Mclean Appointed Chief Scientific Officer |
| June 29, 2007 |
Med BioGene Closes Second And Final Tranche Of Private Placement |
| June 1, 2007 |
Med BioGene Announces Closing Of Private Placement |
| May 30, 2007 |
Med BioGene Inc. Reports Financial Results For The First Quarter 2007 |
| April 30, 2007 |
Med BioGene Inc. Reports Financial Results for 2006 |
| March 27, 2007 |
Med BioGene Announces Private Placement |
| March 19, 2007 |
Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia for Use in Diagnosis, Prognosis and Drug Development |
| February 27, 2007 |
Med BioGene Appoints Dr. Richard C. Cook To Its Scientific Advisory Board |
| February 15, 2007 |
Med BioGene Enters Development Phase for Genetic Screening Test for Colorectal Cancer |
| February 15, 2007 |
Med BioGene Engages the Howard Group Inc. to Provide Investor and Financial Relations Services |
|
